Curis (CRIS) Misses Q1 EPS by 125c May 12, 2026 04:36PM
Curis reports $24.2 million quarterly loss amid clinical trials May 12, 2026 04:00PM
Curis (CRIS) Tops Q4 EPS by 123c Mar 19, 2026 04:08PM
Curis (CRIS) Tops Q4 EPS by 123c Mar 19, 2026 04:08PM
Curis reports Q4 2025 results, raises $20.2 million in financing Mar 19, 2026 04:01PM


Feb 13, 2026 04:24PM Curis (CRIS) files for 107.71M share offering by selling stockholders
Nov 6, 2025 04:00PM Curis reports Q3 net loss narrows to $7.7M from $10.1M year-over-year
Aug 11, 2025 06:03AM Curis (CRIS) Files for 4.62M Share Offering by Selling Stockholders
Aug 5, 2025 09:21AM Curis (CRIS) Misses Q2 EPS by 68c
Aug 5, 2025 08:02AM Curis reports narrowed Q2 loss, advances emavusertib studies
Jul 2, 2025 08:33AM Curis (CRIS) Announces $7M Share and Warrant Offering
May 19, 2025 06:44AM H.C. Wainwright Assumes Curis (CRIS) at Buy
May 6, 2025 04:15PM Curis (CRIS) Misses Q1 EPS by 125c
Apr 1, 2025 06:47AM Curis (CRIS) PT Lowered to $16 at H.C. Wainwright
Mar 31, 2025 08:01AM Curis (CRIS) Provides Q4 Business Update
Dec 23, 2024 08:39AM Curis (CRIS) Files for 2.4M Share Offering by Selling Stockholders
Dec 10, 2024 08:13AM Curis (CRIS) Announces Additional Data from TakeAim Leukemia Study
Nov 14, 2024 04:32PM Curis (CRIS) Misses Q3 EPS by 170c
Nov 14, 2024 08:01AM Curis (CRIS) Issues Q3 Business Update
Nov 4, 2024 06:48AM Curis (CRIS) PT Lowered to $20 at H.C. Wainwright
Oct 29, 2024 06:06AM Curis (CRIS) Prices $12.1M Private Placement at $5.045/unit
Sep 27, 2024 01:59PM Laidlaw Reiterates Buy Rating on Curis (CRIS)
Sep 27, 2024 11:43AM Jones Trading Reiterates Buy Rating on Curis (CRIS)
Sep 27, 2024 06:52AM H.C. Wainwright Reiterates Buy Rating on Curis (CRIS)
Aug 1, 2024 08:22AM Curis (CRIS) Misses Q2 EPS by 203c